PHIO PHARMACEUTICALS CORP (PHIO) Stock Cash Flow
NASDAQ:PHIO - Nasdaq - US71880W5013 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.42M | -10.83M | -11.48M | -13.29M | -8.79M | |||
| Depreciation Amortization | 12.00K | 56.00K | 70.00K | 80.00K | 70.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.01M | -536.00K | -1.26M | 990.00K | -330.00K | |||
| Interest Paid | N/A | N/A | N/A | 10.00K | 10.00K | |||
| Other non cash items | 303.00K | 557.00K | 540.00K | 360.00K | 250.00K | |||
| OPERATING CASH FLOW | -8.11M | -10.75M | -12.13M | -11.86M | -8.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -5.00K | -120.00K | -50.00K | -20.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -5.00K | -120.00K | -50.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 200.00K | |||
| Stock Issued/Repurchased | 5.05M | 7.45M | 0.00 | 21.72M | 15.94M | |||
| Other Financing Activity | -6.00K | -37.00K | -30.00K | 0.00 | -20.00K | |||
| FINANCING CASH FLOW | 5.04M | 7.41M | -30.00K | 21.72M | 16.13M | |||
| CHANGE IN CASH | -3.07M | -3.34M | -12.28M | 9.81M | 7.31M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.11M | -10.75M | -12.13M | -11.86M | -8.80M | |||
| Capital Expenditure | N/A | -5.00K | -120.00K | -50.00K | -20.00K | |||
| FREE CASH FLOW | -8.11M | -10.75M | -12.25M | -11.91M | -8.82M | |||
All data in USD